"Acinetobacter anitratus" 2197 is a bacterium that has multiple antibiotic resistances.
antibiotic resistance genome sequence 16S sequence Bacteria
SI-ID 163
| @ref 20215 |
Last LPSN update
2026-02-09 11:19:37 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Moraxellaceae |
| Genus Acinetobacter |
| Species "Acinetobacter anitratus" |
| Full scientific name Acinetobacter anitratus (Schaub and Hauber 1948) Steel and Cowan 1964 |
| Synonyms (3) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 9085 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive  | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 9085 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 9085 | positive | growth | 30 |
| Test 1 | Test 2 | Test 3 | Test 4 | |
|---|---|---|---|---|
| @ref | 9085 | 9085 | 9085 | 9085 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Müller-Hinton Agar |
| Manual annotation | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 20-22 | 24 | 0 | 20 |
| Ampicillin 10µg (disc) | 0 | 0 | 0 | 0 |
| Aztreonam 30µg (disc) | 14 | 12 | 12 | 16 |
| Bacitracin 10Unit | 0 | 0 | 0 | n.d. |
| Cefalotin 30µg (disc) | 0 | 0 | 0 | n.d. |
| Cefazolin 30µg (disc) | 0 | 0 | 0 | n.d. |
| Cefiderocol 30µg (disc) | n.d. | n.d. | n.d. | 28 |
| Cefotaxime 30µg (disc) | 10-12 | 12 | 10 | 14-16 |
| Ceftazidime 10µg (disc) | n.d. | n.d. | n.d. | 18 |
| Ceftriaxone 30µg (disc) | 12 | 12 | n.d. | 14 |
| Chloramphenicol 30µg (disc) | 0 | 14 | 10 | 8 |
| Ciprofloxacin 5µg (disc) | n.d. | n.d. | n.d. | 32 |
| Clindamycin 10µg (disc) | 8 | 0 | n.d. | 6 |
| Colistin 10µg (disc) | 16 | 14 | 12 | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | n.d. | n.d. | 14 |
| Doxycycline 30µg (disc) | 30 | 28-30 | 16 | n.d. |
| Erythromycin 15µg (disc) | 18-20 | 20 | 10 | 20 |
| Fosfomycin 50µg (disc) | 16-18 | 12 | n.d. | 16 |
| Gentamicin 30µg (disc) | n.d. | n.d. | n.d. | 22 |
| Gentamycin 10µg (disc) | n.d. | |||
| Imipenem 10µg (disc) | 34-36 | 34 | 24 | 38 |
| Kanamycin 30µg (disc) | 22 | 22 | 18 | 22 |
| Levofloxacin 5µg (disc) | n.d. | n.d. | n.d. | 32 |
| Lincomycin 15µg (disc) | 0 | 0 | 0 | n.d. |
| Linezolid 10µg (disc) | 0 | 0 | n.d. | 0 |
| Meropenem 10µg (disc) | n.d. | n.d. | n.d. | 30 |
| Mezlocillin 30µg (disc) | 12 | 10 | 8 | n.d. |
| Moxifloxacin 5µg (disc) | 34 | 32-34 | n.d. | 34 |
| Neomycin 30µg (disc) | 18-20 | 20 | 16 | n.d. |
| Nitrofurantoin 100µg (disc) | 8 | 0 | 0 | 8-10 |
| Norfloxacin 10µg (disc) | 24-26 | 24 | 16 | n.d. |
| Nystatin 100Unit | 0 | 0 | n.d. | n.d. |
| Ofloxacin 5µg (disc) | 30 | 30 | 18 | 30 |
| Oxacillin 5µg (disc) | 0 | 0 | 0 | 0 |
| Penicillin G 6µg (disc) | 0 | 0 | 0 | 0 |
| Pipemidic acid 20µg (disc) | 10 | 10 | 6 | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 24 | 24 | n.d. | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | n.d. | n.d. | 26 |
| Polymyxin B 300Unit | 16 | 16 | 12 | 16 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 | 0 | n.d. | 0 |
| Rifampicin 5µg (disc) | n.d. | n.d. | n.d. | 12 |
| Teicoplanin 30µg (disc) | 0 | 0 | n.d. | 0 |
| Tetracycline 30µg (disc) | 24-26 | 24 | 14 | 28 |
| Ticarcillin 75µg (disc) | 24-26 | 24 | 16 | 26 |
| Tigecycline 15µg (disc) | n.d. | n.d. | n.d. | 26 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | n.d. | n.d. | 0 |
| Vancomycin 30µg (disc) | 0 | 0 | 0 | 0 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68369 | 29016 ChEBI | arginine | - | hydrolysis | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 16899 ChEBI | D-mannitol | - | assimilation | from API 20NE |
| 68369 | 16024 ChEBI | D-mannose | - | assimilation | from API 20NE |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 4853 ChEBI | esculin | - | hydrolysis | from API 20NE |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68369 | 30849 ChEBI | L-arabinose | + | assimilation | from API 20NE |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68369 | 59640 ChEBI | N-acetylglucosamine | - | assimilation | from API 20NE |
| 68369 | 17632 ChEBI | nitrate | - | reduction | from API 20NE |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68369 | 16199 ChEBI | urea | - | hydrolysis | from API 20NE |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 9085 | 28971 | Ampicillin | 10 µg (disc) | from Antibiotic test | |
| 9085 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 9085 | 124991 | Cefalotin | 30 µg (disc) | from Antibiotic test | |
| 9085 | 474053 | Cefazolin | 30 µg (disc) | from Antibiotic test | |
| 9085 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 9085 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | |
| 9085 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 9085 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 9085 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 9085 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test | ||
| 9085 | 29687 | Teicoplanin | 30 µg (disc) | from Antibiotic test | |
| 9085 | Trimethoprim-sulfamethoxazole (1:19) | 10 µg (disc) | from Antibiotic test | ||
| 9085 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
Global distribution of 16S sequence X81667 (>99% sequence identity) for Acinetobacter baumannii from Microbeatlas 
 Aquatic Samples |
4013 |
 Soil Samples |
605 |
 Animal Samples |
5073 |
 Plant Samples |
534 |
| Total Samples | 10225 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Molecular Epidemiological Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Southern Lebanon. | Al Souheil A, Hussein H, Jabbour Z, Barada S, Gerges JR, Derbaj G, Kurdi A, Kazma HJ, Nahouli N, Najem AH, Medlej A, Zorkot W, Hajj RE, Khalil MI, Matar GM, Abou Fayad A. | Antibiotics (Basel) | 10.3390/antibiotics14111124 | 2025 | | |
| Molecular Characteristics of Colistin Resistance in Acinetobacter baumannii and the Activity of Antimicrobial Combination Therapy in a Tertiary Care Medical Center in Lebanon. | Abou Fayad A, Haraoui LP, Sleiman A, Hussein H, Grenier F, Derbaj G, Itani D, Iweir S, Sherri N, Bazzi W, Rasheed S, Tanelian A, Miari M, El Hafi B, Kanj SS, Kanafani ZA, Daoud Z, Araj GF, Matar GM. | Microorganisms | 10.3390/microorganisms12020349 | 2024 | | |
| Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii. | Alexander PJ, Oyama LB, Olleik H, Godoy Santos F, O'Brien S, Cookson A, Cochrane SA, Gilmore BF, Maresca M, Huws SA. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00560-2 | 2024 | | |
| Antibiofilm and cytotoxic metabolites from the entomopathogenic fungus Samsoniella aurantia. | Toshe R, Khalid SJ, Kemkuignou BM, Charria-Giron E, Eckhardt P, Sandargo B, Nuchthien K, Luangsa-Ard JJ, Opatz T, Schrey H, Ebada SS, Stadler M. | Beilstein J Org Chem | 10.3762/bjoc.21.23 | 2025 | | |
| New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development. | Seyfert CE, Muller AV, Walsh DJ, Birkelbach J, Kany AM, Porten C, Yuan B, Krug D, Herrmann J, Marlovits TC, Hirsch AKH, Muller R. | J Med Chem | 10.1021/acs.jmedchem.3c01660 | 2023 | | |
| Analysis of Bacterial Metabolites in Breath Gas of Critically Ill Patients for Diagnosis of Ventilator-Associated Pneumonia-A Proof of Concept Study. | Filipiak W, Wlodarski R, Zuchowska K, Tracewska A, Winiarek M, Daszkiewicz D, Marszalek M, Depka D, Bogiel T. | Biomolecules | 10.3390/biom14121480 | 2024 | | |
| Identification of an Antimicrobial Peptide from the Venom of the Trinidad Thick-Tailed Scorpion Tityus trinitatis with Potent Activity against ESKAPE Pathogens and Clostridioides difficile. | Mechkarska M, Cunning TS, Taggart MG, Ternan NG, Leprince J, Coquet L, Jouenne T, Tena-Garces J, Calvete JJ, Conlon JM. | Antibiotics (Basel) | 10.3390/antibiotics12091404 | 2023 | | |
| Natural peptides and their synthetic congeners acting against Acinetobacter baumannii through the membrane and cell wall: latest progress. | Kumar G. | RSC Med Chem | 10.1039/d4md00745j | 2025 | | |
| Synthetic studies on the tetrasubstituted D-ring of cystobactamids lead to potent terephthalic acid antibiotics. | Stappert M, Kohnhauser D, Seedorf T, Coetzee J, Rox K, Fuchs HLS, Cirnski K, Leitner C, Herrmann J, Kirschning A, Muller R, Bronstrup M. | Commun Chem | 10.1038/s42004-024-01337-6 | 2024 | | |
| Darobactins Exhibiting Superior Antibiotic Activity by Cryo-EM Structure Guided Biosynthetic Engineering. | Seyfert CE, Porten C, Yuan B, Deckarm S, Panter F, Bader CD, Coetzee J, Deschner F, Tehrani KHME, Higgins PG, Seifert H, Marlovits TC, Herrmann J, Muller R. | Angew Chem Int Ed Engl | 10.1002/anie.202214094 | 2023 | | |
| Protoilludene and Alkenoic Acid Derivatives from the European Polypore Fomitiporia hartigii. | Chemutai Sum W, Ebada SS, Wang H, Kellner H, Stadler M. | ACS Omega | 10.1021/acsomega.4c04287 | 2024 | | |
| Bioactive Compounds from an Endophytic Pezicula sp. Showing Antagonistic Effects against the Ash Dieback Pathogen | Demir O, Zeng H, Schulz B, Schrey H, Steinert M, Stadler M, Surup F. | Biomolecules | 2023 | | ||
| Sporothioethers: deactivated alkyl citrates from the fungus Hypomontagnella monticulosa. | Heinemann H, Becker K, Schrey H, Zeng H, Stadler M, Cox RJ. | RSC Adv | 10.1039/d3ra06542a | 2023 | | |
| Furaquinocins K and L: Novel Naphthoquinone-Based Meroterpenoids from Streptomyces sp. Je 1-369. | Tistechok S, Stierhof M, Myronovskyi M, Zapp J, Gromyko O, Luzhetskyy A. | Antibiotics (Basel) | 10.3390/antibiotics11111587 | 2022 | | |
| Comprehensive Cell Biological Investigation of Cytochalasin B Derivatives with Distinct Activities on the Actin Network. | Kagho MD, Schmidt K, Lambert C, Kaufmann T, Jia L, Faix J, Rottner K, Stadler M, Stradal T, Klahn P. | J Nat Prod | 10.1021/acs.jnatprod.4c00676 | 2024 | | |
| Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112. | Kolano L, Knappe D, Berg A, Berg T, Hoffmann R. | Chembiochem | 10.1002/cbic.202100609 | 2022 | | |
| Early Molecular Insights into Thanatin Analogues Binding to A. baumannii LptA. | Oi KK, Moehle K, Schuster M, Zerbe O. | Molecules | 10.3390/molecules28114335 | 2023 | | |
| Preparation, Characterization and Antimicrobial Properties of Nanosized Silver-Containing Carbon/Silica Composites from Rice Husk Waste. | Unglaube F, Lammers A, Kreyenschulte CR, Lalk M, Mejia E. | ChemistryOpen | 10.1002/open.202100239 | 2021 | | |
| Unconventional semi-solid cultivation enhances cytochalasins production by the Colombian fungus Xylaria sp. CM-UDEA-H199. | Valencia-Revelo D, Charria-Giron E, Schmidt K, Reinecke S, Vasco-Palacios AM, Stradal T, Marin-Felix Y, Caicedo-Ortega NH, Ebada SS. | BMC Biotechnol | 10.1186/s12896-025-00978-2 | 2025 | | |
| Bioprospection of Tenellins Produced by the Entomopathogenic Fungus Beauveria neobassiana. | Toshe R, Charria-Giron E, Khonsanit A, Luangsa-Ard JJ, Khalid SJ, Schrey H, Ebada SS, Stadler M. | J Fungi (Basel) | 10.3390/jof10010069 | 2024 | | |
| Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering. | Gross S, Panter F, Pogorevc D, Seyfert CE, Deckarm S, Bader CD, Herrmann J, Muller R. | Chem Sci | 10.1039/d1sc02725e | 2021 | | |
| An Application of Imipenem Discs or P. aeruginosa ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria. | Bogiel T, Rzepka M, Gospodarek-Komkowska E. | Antibiotics (Basel) | 10.3390/antibiotics10070875 | 2021 | | |
| Cyclofaulknamycin with the Rare Amino Acid D-capreomycidine Isolated from a Well-Characterized Streptomyces albus Strain. | Horbal L, Stierhof M, Palusczak A, Eckert N, Zapp J, Luzhetskyy A. | Microorganisms | 10.3390/microorganisms9081609 | 2021 | | |
| Phylogeny | Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. | Mencacci A, Monari C, Leli C, Merlini L, De Carolis E, Vella A, Cacioni M, Buzi S, Nardelli E, Bistoni F, Sanguinetti M, Vecchiarelli A. | J Clin Microbiol | 10.1128/jcm.01811-12 | 2013 | |
| Strong antagonism of an endophyte of Fraxinus excelsior towards the ash dieback pathogen, Hymenoscyphus fraxineus, is mediated by the antifungal secondary metabolite PF1140. | Demir O, Schulz B, Rabsch L, Steinert M, Surup F. | Appl Environ Microbiol | 10.1128/aem.00665-24 | 2024 | | |
| Pathogenicity | Ribosomal Target-Binding Sites of Antimicrobial Peptides Api137 and Onc112 Are Conserved among Pathogens Indicating New Lead Structures To Develop Novel Broad-Spectrum Antibiotics. | Kolano L, Knappe D, Volke D, Strater N, Hoffmann R. | Chembiochem | 10.1002/cbic.202000109 | 2020 | |
| Arcopilins: A New Family of Staphylococcus aureus Biofilm Disruptors from the Soil Fungus Arcopilus navicularis. | Charria-Giron E, Zeng H, Gorelik TE, Pahl A, Truong KN, Schrey H, Surup F, Marin-Felix Y. | J Med Chem | 10.1021/acs.jmedchem.4c00585 | 2024 | | |
| Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models. | Rox K, Jansen R, Lukezic T, Greweling-Pils M, Herrmann J, Miethke M, Huttel S, Hennessen F, Abou Fayad A, Holzhausen C, Lundberg CV, Teague J, Sudarman E, Bulter L, Hesterkamp T, Stadler M, Bronstrup M, Muller R. | Microbiol Spectr | 10.1128/spectrum.01289-23 | 2024 | | |
| Photobacterium arenosum WH24, Isolated from the Gill of Pacific Oyster Crassostrea gigas from the North Sea of Germany: Co-cultivation and Prediction of Virulence. | Pira H, Risdian C, Musken M, Schupp PJ, Wink J. | Curr Microbiol | 10.1007/s00284-022-02909-2 | 2022 | | |
| Pathogenicity | Synthesis and Bioactivity of Ancorinoside B, a Marine Diglycosyl Tetramic Acid. | Soliga KJ, Bar SI, Oberhuber N, Zeng H, Schrey H, Schobert R. | Mar Drugs | 10.3390/md19100583 | 2021 | |
| Metabolism | Genome-Guided Discovery of the First Myxobacterial Biarylitide Myxarylin Reveals Distinct C-N Biaryl Crosslinking in RiPP Biosynthesis. | Hug JJ, Frank NA, Walt C, Senica P, Panter F, Muller R. | Molecules | 10.3390/molecules26247483 | 2021 | |
| Rapid identification of Acinetobacter spp. by fluorescence in situ hybridization (FISH) from colony and blood culture material. | Frickmann H, Essig A, Hagen RM, Riecker M, Jerke K, Ellison D, Poppert S. | Eur J Microbiol Immunol (Bp) | 10.1556/eujmi.1.2011.4.4 | 2011 | | |
| Discovery and overproduction of novel highly bioactive pamamycins through transcriptional engineering of the biosynthetic gene cluster. | Eckert N, Rebets Y, Horbal L, Zapp J, Herrmann J, Busche T, Muller R, Kalinowski J, Luzhetskyy A. | Microb Cell Fact | 10.1186/s12934-023-02231-x | 2023 | | |
| Pathogenicity | COX Inhibitory and Cytotoxic Naphthoketal-Bearing Polyketides from Sparticola junci. | Garcia KYM, Quimque MTJ, Primahana G, Ratzenbock A, Cano MJB, Llaguno JFA, Dahse HM, Phukhamsakda C, Surup F, Stadler M, Macabeo APG. | Int J Mol Sci | 10.3390/ijms222212379 | 2021 | |
| Exploring the Antibiotic Production Potential of Heterotrophic Bacterial Communities Isolated from the Marine Sponges Crateromorpha meyeri, Pseudaxinella reticulata, Farrea similaris, and Caulophacus arcticus through Synergistic Metabolomic and Genomic Analyses. | Tareen S, Schupp PJ, Iqbal N, Wink J. | Mar Drugs | 10.3390/md20070463 | 2022 | | |
| Synthetic studies of cystobactamids as antibiotics and bacterial imaging carriers lead to compounds with high in vivo efficacy. | Testolin G, Cirnski K, Rox K, Prochnow H, Fetz V, Grandclaudon C, Mollner T, Baiyoumy A, Ritter A, Leitner C, Krull J, van den Heuvel J, Vassort A, Sordello S, Hamed MM, Elgaher WAM, Herrmann J, Hartmann RW, Muller R, Bronstrup M. | Chem Sci | 10.1039/c9sc04769g | 2019 | | |
| Phylogeny | Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. | Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F. | J Clin Microbiol | 10.1128/jcm.43.9.4382-4390.2005 | 2005 | |
| Optimization of the Central alpha-Amino Acid in Cystobactamids to the Broad-Spectrum, Resistance-Breaking Antibiotic CN-CC-861. | Kohnhauser D, Seedorf T, Cirnski K, Heimann D, Coetzee J, Sordello S, Richter J, Stappert M, Sabuco JF, Corbett D, Bacque E, Rox K, Herrmann J, Vassort A, Muller R, Kirschning A, Bronstrup M. | J Med Chem | 10.1021/acs.jmedchem.4c00927 | 2024 | | |
| Enzymology | Development of a genus-specific next generation sequencing approach for sensitive and quantitative determination of the Legionella microbiome in freshwater systems. | Pereira RP, Peplies J, Brettar I, Hofle MG. | BMC Microbiol | 10.1186/s12866-017-0987-5 | 2017 | |
| Metabolism | Effects of Halide Ions on the Carbamidocyclophane Biosynthesis in Nostoc sp. CAVN2. | Preisitsch M, Heiden SE, Beerbaum M, Niedermeyer TH, Schneefeld M, Herrmann J, Kumpfmuller J, Thurmer A, Neidhardt I, Wiesner C, Daniel R, Muller R, Bange FC, Schmieder P, Schweder T, Mundt S. | Mar Drugs | 10.3390/md14010021 | 2016 | |
| Variation in type IV pilus stability modulates DNA uptake and biofilm formation. | Yu Y, Mahdi R, Al-Hilfy Leon A, Vo N, Lofgren R, Mutabazi JL, Piepenbrink KH. | J Biol Chem | 10.1016/j.jbc.2025.110787 | 2025 | | |
| Cinnamaldehyde and baicalin reverse colistin resistance in Enterobacterales and Acinetobacter baumannii strains. | Mireles NA, Malla CF, Tavio MM. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-024-04884-x | 2024 | | |
| Mining the heparinome for cryptic antimicrobial peptides that selectively kill Gram-negative bacteria. | Bello-Madruga R, Sandin D, Valle J, Gomez J, Comas L, Larrosa MN, Gonzalez-Lopez JJ, Jimenez MA, Andreu D, Torrent M. | Mol Syst Biol | 10.1038/s44320-025-00120-6 | 2025 | | |
| Development of Naphthalene-Derivative Bis-QACs as Potent Antimicrobials: Unraveling Structure-Activity Relationship and Microbiological Properties. | Frolov NA, Seferyan MA, Detusheva EV, Son E, Kolmakov IG, Kartseva AS, Firstova VV, Vereshchagin AN, Elinson MN. | Molecules | 10.3390/molecules29235526 | 2024 | | |
| From In Vitro Promise to In Vivo Reality: An Instructive Account of Infection Model Evaluation of Antimicrobial Peptides. | Carrera-Aubesart A, Li J, Contreras E, Bello-Madruga R, Torrent M, Andreu D. | Int J Mol Sci | 10.3390/ijms25189773 | 2024 | | |
| Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [D(KLAKLAK)2] increases antimicrobial activities against multidrug-resistant Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli. | Ohno MK, Kirikae T, Yoshihara E, Kirikae F, Ishida I. | PeerJ | 10.7717/peerj.10176 | 2020 | | |
| The Antimicrobial and Antibiofilm Potential of New Water-Soluble Tris-Quaternary Ammonium Compounds. | Frolov NA, Seferyan MA, Valeev AB, Saverina EA, Detusheva EV, Vereshchagin AN. | Int J Mol Sci | 10.3390/ijms241310512 | 2023 | | |
| The C-Terminus of Panusin, a Lobster beta-Defensin, Is Crucial for Optimal Antimicrobial Activity and Serum Stability. | Bello-Madruga R, Valle J, Jimenez MA, Torrent M, Montero-Alejo V, Andreu D. | Pharmaceutics | 10.3390/pharmaceutics15061777 | 2023 | | |
| Investigating the Antibacterial Activity and Safety of Zinc Oxide Nanoparticles versus a Commercial Alcohol-Based Hand-Sanitizer: Can Zinc Oxide Nanoparticles Be Useful for Hand Sanitation? | Ismail A, Raya NR, Orabi A, Ali AM, Abo-Zeid Y. | Antibiotics (Basel) | 10.3390/antibiotics11111606 | 2022 | | |
| In Vivo Evaluation of ECP Peptide Analogues for the Treatment of Acinetobacter baumannii Infection. | Li J, Prats-Ejarque G, Torrent M, Andreu D, Brandenburg K, Fernandez-Millan P, Boix E. | Biomedicines | 10.3390/biomedicines10020386 | 2022 | | |
| Regulation of tert-Butyl Hydroperoxide Resistance by Chromosomal OhrR in A. baumannii ATCC 19606. | Chen SJ, Shu HY, Lin GH. | Microorganisms | 10.3390/microorganisms9030629 | 2021 | | |
| Examining Topoisomers of a Snake-Venom-Derived Peptide for Improved Antimicrobial and Antitumoral Properties. | Carrera-Aubesart A, Defaus S, Perez-Peinado C, Sandin D, Torrent M, Jimenez MA, Andreu D. | Biomedicines | 10.3390/biomedicines10092110 | 2022 | | |
| Structure-Based Design of an RNase Chimera for Antimicrobial Therapy. | Prats-Ejarque G, Lorente H, Villalba C, Anguita R, Lu L, Vazquez-Monteagudo S, Fernandez-Millan P, Boix E. | Int J Mol Sci | 10.3390/ijms23010095 | 2021 | | |
| The primary transcriptome, small RNAs and regulation of antimicrobial resistance in Acinetobacter baumannii ATCC 17978. | Kroger C, MacKenzie KD, Alshabib EY, Kirzinger MWB, Suchan DM, Chao TC, Akulova V, Miranda-CasoLuengo AA, Monzon VA, Conway T, Sivasankaran SK, Hinton JCD, Hokamp K, Cameron ADS. | Nucleic Acids Res | 10.1093/nar/gky603 | 2018 | | |
| Global assessment of small RNAs reveals a non-coding transcript involved in biofilm formation and attachment in Acinetobacter baumannii ATCC 17978. | Alvarez-Fraga L, Rumbo-Feal S, Perez A, Gomez MJ, Gayoso C, Vallejo JA, Ohneck EJ, Valle J, Actis LA, Beceiro A, Bou G, Poza M. | PLoS One | 10.1371/journal.pone.0182084 | 2017 | | |
| Enzymology | A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates. | Menon ND, Kumar MS, Satheesh Babu TG, Bose S, Vijayakumar G, Baswe M, Chatterjee M, D'Silva JR, Shetty K, Haripriyan J, Kumar A, Nair S, Somanath P, Nair BG, Nizet V, Kumar GB. | mSphere | 10.1128/msphere.01215-20 | 2021 | |
| Metabolism | Identification of novel regulatory small RNAs in Acinetobacter baumannii. | Sharma R, Arya S, Patil SD, Sharma A, Jain PK, Navani NK, Pathania R. | PLoS One | 10.1371/journal.pone.0093833 | 2014 | |
| Pathogenicity | Rationally Modified Antimicrobial Peptides from the N-Terminal Domain of Human RNase 3 Show Exceptional Serum Stability. | Sandin D, Valle J, Chaves-Arquero B, Prats-Ejarque G, Larrosa MN, Gonzalez-Lopez JJ, Jimenez MA, Boix E, Andreu D, Torrent M. | J Med Chem | 10.1021/acs.jmedchem.1c00795 | 2021 | |
| Enzymology | Cloning and characterization of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) transferase genes (kdtA) from Acinetobacter baumannii and Acinetobacter haemolyticus. | Bode CE, Brabetz W, Brade H. | Eur J Biochem | 10.1046/j.1432-1327.1998.2540404.x | 1998 | |
| Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae. | Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD. | PLoS One | 10.1371/journal.pone.0128532 | 2015 | | |
| Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides. | Pantophlet R, Severin JA, Nemec A, Brade L, Dijkshoorn L, Brade H. | Clin Diagn Lab Immunol | 10.1128/cdli.9.1.60-65.2002 | 2002 | | |
| Metabolism | Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. | Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW, Cox AD, St Michael F, Vinogradov EV, Campagnari AA. | Infect Immun | 10.1128/iai.00016-10 | 2010 | |
| Phylogeny | O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies. | Pantophlet R, Nemec A, Brade L, Brade H, Dijkshoorn L. | J Clin Microbiol | 10.1128/jcm.39.7.2576-2580.2001 | 2001 | |
| The bioactivity of plant extracts against representative bacterial pathogens of the lower respiratory tract. | Bocanegra-Garcia V, Del Rayo Camacho-Corona M, Ramirez-Cabrera M, Rivera G, Garza-Gonzalez E. | BMC Res Notes | 10.1186/1756-0500-2-95 | 2009 | | |
| Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses. | Smeekens SP, Huttenhower C, Riza A, van de Veerdonk FL, Zeeuwen PL, Schalkwijk J, van der Meer JW, Xavier RJ, Netea MG, Gevers D. | J Innate Immun | 10.1159/000351912 | 2014 | | |
| Metabolism | Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation. | Pulido D, Arranz-Trullen J, Prats-Ejarque G, Velazquez D, Torrent M, Moussaoui M, Boix E. | Int J Mol Sci | 10.3390/ijms17040552 | 2016 | |
| Phylogeny | Characterization of Acinetobacter type strains and isolates obtained from wastewater treatment plants by PCR fingerprinting. | Wiedmann-al-Ahmad M, Tichy HV, Schon G. | Appl Environ Microbiol | 10.1128/aem.60.11.4066-4071.1994 | 1994 | |
| Time-Resolved Transcriptional Profiling of Epithelial Cells Infected by Intracellular Acinetobacter baumannii. | Crua Asensio N, Macho Rendon J, Torrent Burgas M. | Microorganisms | 10.3390/microorganisms9020354 | 2021 | | |
| Can Eucalyptol Replace Antibiotics? | Maczka W, Duda-Madej A, Gorny A, Grabarczyk M, Winska K. | Molecules | 10.3390/molecules26164933 | 2021 | | |
| Antimicrobial Activity of Several Cineole-Rich Western Australian Eucalyptus Essential Oils. | Aldoghaim FS, Flematti GR, Hammer KA. | Microorganisms | 10.3390/microorganisms6040122 | 2018 | | |
| Pathogenicity | Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel. | Simhon A, Rahav G, Shazberg G, Block C, Bercovier H, Shapiro M. | J Clin Microbiol | 10.1128/jcm.39.1.389-391.2001 | 2001 | |
| The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. | Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. | PLoS One | 10.1371/journal.pone.0010034 | 2010 | | |
| Essential Oils and Supercritical CO2 Extracts of Arctic Angelica (Angelica archangelica L.), Marsh Labrador Tea (Rhododendron tomentosum) and Common Tansy (Tanacetum vulgare)-Chemical Compositions and Antimicrobial Activities. | Korpinen RI, Valimaa AL, Liimatainen J, Kunnas S. | Molecules | 10.3390/molecules26237121 | 2021 | | |
| Enzymology | Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides. | Pantophlet R, Brade L, Brade H. | Clin Diagn Lab Immunol | 10.1128/cdli.6.3.323-329.1999 | 1999 | |
| Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter. | Pantophlet R, Brade L, Dijkshoorn L, Brade H. | J Clin Microbiol | 10.1128/jcm.36.5.1245-1250.1998 | 1998 | | |
| Phylogeny | Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. | Gerner-Smidt P. | J Clin Microbiol | 10.1128/jcm.30.10.2680-2685.1992 | 1992 | |
| Phylogeny | Validation of use of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex and application of the method to the investigation of a hospital outbreak. | Snelling AM, Gerner-Smidt P, Hawkey PM, Heritage J, Parnell P, Porter C, Bodenham AR, Inglis T. | J Clin Microbiol | 10.1128/jcm.34.5.1193-1202.1996 | 1996 | |
| Phylogeny | Species, biotype, and bacteriophage type determinations compared with cell envelope protein profiles for typing Acinetobacter strains. | Bouvet PJ, Jeanjean S, Vieu JF, Dijkshoorn L. | J Clin Microbiol | 10.1128/jcm.28.2.170-176.1990 | 1990 | |
| Phylogeny | Reliability of phenotypic tests for identification of Acinetobacter species. | Gerner-Smidt P, Tjernberg I, Ursing J. | J Clin Microbiol | 10.1128/jcm.29.2.277-282.1991 | 1991 | |
| Pathogenicity | Diversity of Sequence Types and Impact of Fitness Cost among Carbapenem-Resistant Acinetobacter baumannii Isolates from Tripoli, Libya. | Abou Fayad AG, Haraoui LP, Sleiman A, Jaafar M, Zorgani A, Matar GM, Higgins PG | Antimicrob Agents Chemother | 10.1128/AAC.00277-21 | 2021 | |
| Pathogenicity | From bugs to drugs: Combating antimicrobial resistance by discovering novel antibiotics. | Abou Fayad A, Itani D, Miari M, Tanelian A, Iweir S, Matar GM | J Infect Dev Ctries | 10.3855/jidc.10108 | 2018 | |
| Unprecedented Antimicrobial and Cytotoxic Polyketides from Cultures of Diaporthe africana sp. nov. | Matio Kemkuignou B, Lambert C, Stadler M, Kouam Fogue S, Marin-Felix Y. | J Fungi (Basel) | 10.3390/jof9070781 | 2023 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive8094.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License